Intravenous rosuvastatin for acute stroke treatment: an animal study.
about
Update on Inflammatory Biomarkers and Treatments in Ischemic StrokeIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesStatin post-treatment provides protection against simulated ischemia in bovine pulmonary arterial endothelial cells.Assessing post-stroke behavior in mouse models of focal ischemia.Delayed postconditioning protects against focal ischemic brain injury in rats.High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART)Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator.Comparison of the post-embolization effects of tissue-plasminogen activator and simvastatin on neurological outcome in a clinically relevant rat model of acute ischemic stroke.Rosuvastatin calcium in acute coronary syndromes.Delayed combination therapy of local brain hypothermia and decompressive craniectomy on acute stroke outcome in rat.The many roles of statins in ischemic strokeThe Effect of Statins and Other Cardiovascular Medication on Ischemia-Reperfusion Damage in a Human DIEP Flap Model: Theoretical and Epidemiological ConsiderationsNitric oxide: considerations for the treatment of ischemic stroke.Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2.An overview of the extra-lipid effects of rosuvastatin.Statins in traumatic brain injury.Statins therapy: a review on conventional and novel formulation approaches.Systematic review and meta-analysis of the efficacy of statins in experimental stroke.Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury.Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke.Stroke: do statins improve outcomes after acute ischemic stroke?Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemiaThe rapid lipopolysaccharide-induced release of matrix metalloproteinases 9 is suppressed by simvastatin.Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats.MRI heralds secondary nigral lesion after brain ischemia in mice: a secondary time window for neuroprotection.Intratracheal instillation of pravastatin for the treatment of murine allergic asthma: a lung-targeted approach to deliver statins.Statin use before and after acute ischemic stroke onset improves neurological outcome.CoQ10 Augments Rosuvastatin Neuroprotective Effect in a Model of Global Ischemia via Inhibition of NF-κB/JNK3/Bax and Activation of Akt/FOXO3A/Bim Cues.The Effects of Atorvastatin on Inflammatory Responses and Mortality in Septic Shock: A Single-center, Randomized Controlled Trial.Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study.
P2860
Q28078744-2E99CB4E-DF69-4947-BCBD-398531C1194CQ28388335-4129F655-CB45-4EC8-A632-135BBAC3A892Q30431767-17275D54-F23F-4EAD-BDF5-C94915A309F5Q30537173-DB0B9F15-B7FE-4753-841D-60EF581BA7E2Q33391388-4304C3AB-4E30-467D-923A-507B3179470EQ33621245-DD476AFE-AA31-471B-8759-49A22E3A55D9Q33976397-C30389F1-F146-453F-878F-43F6E8DAEF17Q34207727-9C7A56E1-836E-4134-93F7-058802CBD350Q34338367-26D16230-A1DF-4E15-943A-70110A7C3D5BQ34567097-801D7C07-2866-487A-A40A-9DF6EE867702Q35595431-B4CCA1C5-EFFD-4F4E-A6FA-BC5B1A0ACFB2Q35977679-3C937F5C-0F45-4516-AF04-14FD723A7A84Q36079329-38F205B8-B6A9-4F4A-AA2A-D165F06DD94AQ36702523-75174A5E-7CDB-4EC4-B758-9E78F3C137BDQ37156139-321E9C83-DACE-4E29-AE06-6B75831C580FQ37374151-93ED3C63-75C4-4018-A15E-F0F17DCC5EB4Q37896125-63050FE5-45B3-47E7-9473-93E2B9E8AB26Q37977533-23E94D5C-73D0-4C9B-B965-1EA4EA61AD55Q38030379-175FCE45-3901-47D6-BF03-B1090DD4B4BDQ38366399-1F1EE23A-5034-4861-B4F6-D1B0659D681BQ39576834-AF3291E0-6667-4024-9AE5-E5E503BDADC9Q40625919-DBE2F23A-F6A0-4090-AA2A-F06E2DBFDC16Q41543138-F66A4B93-2454-4B3E-A933-8D17C910E65AQ41815413-66572039-1FBE-471F-A726-70BCE36DCBABQ41848302-FF44FE53-AE23-4A6D-8C94-1B235F5FEBC9Q42530785-88696F32-C97F-440D-BE3E-267EC589F325Q43265095-318556CB-2BE9-4B91-99CB-BF651E48B966Q46679067-21D0EED2-B15F-422F-BD1C-3D4BB29904A1Q47106552-E6C90BE7-6526-40D4-9E1A-0B549C930458Q48003024-1B63E29E-9D43-4063-B18A-B8AF79A559EE
P2860
Intravenous rosuvastatin for acute stroke treatment: an animal study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Intravenous rosuvastatin for acute stroke treatment: an animal study.
@en
Intravenous rosuvastatin for acute stroke treatment: an animal study.
@nl
type
label
Intravenous rosuvastatin for acute stroke treatment: an animal study.
@en
Intravenous rosuvastatin for acute stroke treatment: an animal study.
@nl
prefLabel
Intravenous rosuvastatin for acute stroke treatment: an animal study.
@en
Intravenous rosuvastatin for acute stroke treatment: an animal study.
@nl
P2093
P1433
P1476
Intravenous rosuvastatin for acute stroke treatment: an animal study.
@en
P2093
Christoph Leithner
Karen Gertz
Matthias Endres
Mustafa Balkaya
Ulrich Laufs
Vincent Prinz
P304
P356
10.1161/STROKEAHA.107.492470
P407
P577
2007-12-27T00:00:00Z